Skip to main content
Larissa Furtado, MD, Pathology, Memphis, TN, St. Jude Children's Research Hospital

LarissaVianaFurtadoMD

Pathology Memphis, TN

Molecular Genetics, Anatomic Pathology, Clinical Pathology

Medical Director, Molecular Oncology

Dr. Furtado is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Furtado's full profile

Already have an account?

Education & Training

  • University of Michigan Health System
    University of Michigan Health SystemFellowship, Molecular Genetic Pathology, 2012 - 2013
  • University of Utah Health
    University of Utah HealthResidency, Pathology-Anatomic and Clinical, 2008 - 2012
  • Other
    OtherClass of 2002

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2019 - 2025
  • TN State Medical License
    TN State Medical License 2019 - 2025
  • UT State Medical License
    UT State Medical License 2009 - 2022
  • IL State Medical License
    IL State Medical License 2013 - 2017
  • MI State Medical License
    MI State Medical License 2012 - 2013
  • American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • American Board of Pathology Clinical Informatics
  • American Board of Pathology Pathology - Molecular Genetic

Publications & Presentations

PubMed

Journal Articles

  • Original Contribution Tumor PD-L1 Expression in Malignant Pleural and Peritoneal Mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28–8 pharmDx Assays☆☆☆☆☆☆  
    Aliya N Husain, Georgios Deftereos, Larissa V Furtado, ScienceDirect

Press Mentions

  • Highs, Lows of Tumor Mutation Burden Testing
    Highs, Lows of Tumor Mutation Burden TestingSeptember 20th, 2022
  • CAP Publishes Guideline for PD-L1 Testing of Patients with Lung Cancer
    CAP Publishes Guideline for PD-L1 Testing of Patients with Lung CancerApril 17th, 2024

Committees

  • Reviewer, Molecular Methods Consensus Committee, Clinical and Laboratory Standard Institute (CLSI) 2014 - 2015
  • Junior Member, Clinical Practice Committee, Association for Molecular Pathology 2013 - 2014
  • Junior Member, Biochemical Genetics & Molecular Genetics Resource Committee, College of American Pathologists /American College of Medical Genetics and Genomics 2012 - 2013

Professional Memberships

Other Languages

  • Portuguese

Hospital Affiliations